MS

Mark S. Smyth

OT Onyx Therapeutics: 17 patents #2 of 49Top 5%
PH Pharmacyclics: 14 patents #12 of 113Top 15%
PR Proteolix: 3 patents #2 of 12Top 20%
EL Eli Lilly: 2 patents #1,306 of 2,858Top 50%
PP Portola Pharmaceuticals: 1 patents #31 of 61Top 55%
US US Dept of Health & Human Services: 1 patents #1,144 of 3,044Top 40%
CT Cor Therapeutics: 1 patents #28 of 54Top 55%
📍 Foster City, CA: #70 of 2,058 inventorsTop 4%
🗺 California: #10,935 of 386,348 inventorsTop 3%
Overall (All Time): #76,361 of 4,157,543Top 2%
41
Patents All Time

Issued Patents All Time

Showing 1–25 of 41 patents

Patent #TitleCo-InventorsDate
10961251 Crystalline forms of a Bruton's tyrosine kinase inhibitor Norbert Purro, Erick Goldman, David D. Wirth 2021-03-30
10752634 Crystalline forms of a brutons tyrosine kinase inhibitor Norbert Purro, Erick Goldman, David D. Wirth 2020-08-25
10294231 Crystalline forms of a Bruton's tyrosine kinase inhibitor Norbert Purro, Erick Goldman, David D. Wirth 2019-05-21
10294232 Crystalline forms of a Bruton's tyrosine kinase inhibitor Norbert Purro, Erick Goldman, David D. Wirth 2019-05-21
10266540 Crystalline forms of a Bruton's tyrosine kinase inhibitor Norbert Purro, Erick Goldman, David D. Wirth 2019-04-23
10125140 Crystalline forms of a bruton's tyrosine kinase inhibitor Norbert Purro, Erick Goldman, David D. Wirth 2018-11-13
10106548 Crystalline forms of a Bruton's tyrosine kinase inhibitor Norbert Purro, Erick Goldman, David D. Wirth 2018-10-23
10065968 Crystalline forms of a bruton's tyrosine kinase inhibitor Norbert Purro, Erick Goldman, David D. Wirth 2018-09-04
9828383 Crystalline forms of a bruton's tyrosine kinase inhibitor Norbert Purro, Erick Goldman, David D. Wirth 2017-11-28
9725455 Crystalline forms of a bruton's tyrosine kinase inhibitor Norbert Purro, Erick Goldman, David D. Wirth 2017-08-08
9713617 Crystalline forms of a Bruton's tyrosine kinase inhibitor Norbert Purro, Erick Goldman, David D. Wirth 2017-07-25
9657058 Compounds for enzyme inhibition Kevin D. Shenk, Francesco Parlati, Han-Jie Zhou, Catherine Sylvain, Mark K. Bennett +1 more 2017-05-23
9540382 Crystalline forms of a Bruton's tyrosine kinase inhibitor Norbert Purro, Erick Goldman, David D. Wirth 2017-01-10
9296753 Crystalline forms of a Bruton's tyrosine kinase inhibitor Erick Goldman, David D. Wirth, Norbert Purro 2016-03-29
9012463 Inhibitors of bruton's tyrosine kinase Wei Chen, David J. Loury, Tarak D. Mody, Erik Verner, Wenchen Luo 2015-04-21
8765745 Compounds for enzyme inhibition Kevin D. Shenk, Francesco Parlati, Han-Jie Zhou, Catherine Sylvain, Mark K. Bennett +1 more 2014-07-01
8735441 Compounds for enzyme inhibition Kevin D. Shenk, Francesco Parlati, Han-Jie Zhou, Catherine Sylvain, Mark K. Bennett +1 more 2014-05-27
8609654 Compounds for enzyme inhibition Kevin D. Shenk, Francesco Parlati, Catherine Sylvain, Mark K. Bennett, Guy J. Laidig +1 more 2013-12-17
8431571 Compounds for enzyme inhibition Kevin D. Shenk, Francesco Parlati, Han-Jie Zhou, Catherine Sylvain, Mark K. Bennett +1 more 2013-04-30
8357683 Compounds for enzyme inhibition Kevin D. Shenk, Francesco Parlati, Han-Jie Zhou, Catherine Sylvain, Mark K. Bennett +1 more 2013-01-22
8324174 Compounds for enzyme inhibition Guy J. Laidig, Ronald T. Borchardt, Barry A. Bunin, Craig M. Crews, John H. Musser 2012-12-04
8207126 Compounds for enzyme inhibition Guy J. Laidig 2012-06-26
8207124 Compounds for enzyme inhibition Guy J. Laidig 2012-06-26
8207125 Compounds for enzyme inhibition Guy J. Laidig 2012-06-26
8207127 Compounds for enzyme inhibition Guy J. Laidig 2012-06-26